Royal Giving Day 2019 Outcomes
Royal Giving Day 2019 Outcomes
The response to our inaugural Royal Giving Day in 2019 was simply overwhelming. Thanks to the generosity of corporate and community donors, RBWH Foundation was able to raise just over $500,000.
All of those funds, 100%, have been allocated to RBWH clinical priorities – research, staff education and training; and patient care.
In 2021, with your help, we can save even more lives, fund more research and support additional patient friendly projects.
ICU: Antibiotic dosing in critically ill patients
• Evaluation of what is called ‘off-label’ dosing of antibiotics for critically-ill patients as standard doses, available from pharmacies, haven’t been tested in ICU situations
Burns: innovation in delirium management
• Whether we decrease delirium in intensive care patients with the use of clonidine using two alternate delivery methods
Neuorology: MEND and MND projects
• Investigating the immunometabolic nature of motor neurone disease (MND): a study linking metabolism, inflammation, and clinical outcomes in MND patients
Cancer: Skull based cancer research
• Development of more advanced MR imaging to better inform surgeons during invasive skull base cancer surgery, and research into non-surgical treatments such as immunotherapy to avoid destructive surgery
• Study into team-based management of all aspects of spinal care, through exposure in the tertiary setting to simple and complex spinal deformity, trauma, and spinal oncology
Allied health: Non-surgical management of knee osteoarthritis
• Testing a screening instrument to select people with knee osteoarthritis most likely to benefit from non-surgical care.
Ideal catheter to vein ratio parameters for peripheral venous and midline devices
• The DIAMETER study: how to determine the right size catheter for a vein to prevent device failure.
Imaging and DNA markers for non-penetrating traumatic brain injury
• Can advanced medical imaging and a blood test for DNA markers predict outcome following brain injury.
Measure and map gene activity to determine kidney disease pathways and optimise kidney biopsy assessment
• Use of a ground-breaking gene technology, Spatial Transcriptomics, to examine kidney disease and facilitate kidney biopsies.
Staff education and training
Video conferencing rooms
• The purchase of equipment to upgrade five conference rooms across RBWH to support international conferencing for training, research capabilities/partnerships and functionality through virtual meetings.
NeoRESQ ‘NeoReturn’ vehicle
• NeoReturn is Queensland’s first neonatal service to safely transfer babies and families to a hospital closer to home after receiving neonatal intensive care at RBWH
Delta therapy dogs
• Therapy dogs are trained to provide affection, comfort and support to patients
Patient lounge upgrades
• To provide privacy for families to meet and a quiet space for sometimes difficult conversations to be held
Patients in need
• Clothing for vulnerable patients admitted to RBWH as a result of trauma, sexual assault or homeless.
- S Prev